SCHEMBL6171023

SCHEMBL6171023

CCc1ccc(N)c(C=CC(=O)OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.47
▸ MAPT P10636 4/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ HPGD P15428 2/20 0.47
▸ ALOX15 P16050 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ GAA P10253 2/20 0.44
▸ TSHR P16473 1/20 0.44
▸ TTR P02766 1/20 0.41
▸ APP P05067 1/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ TYR P14679 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171017 1.00 ALDH1A1 (0.47) ALDH1A1MAPTKDM4EHPGDALOX15
SCHEMBL6171404 0.88 ALDH1A1 (0.47) ALDH1A1MAPTKDM4EHPGDALOX15
SCHEMBL6171397 0.88 ALDH1A1 (0.47) ALDH1A1MAPTKDM4EHPGDALOX15
SCHEMBL14465342 0.86 ALDH1A1 (0.55) ALDH1A1MAPTKDM4EHPGDALOX15
SCHEMBL8125136 0.83 EGFR (0.50) ALDH1A1KDM4EGAACA1CA2
SCHEMBL8125134 0.83 EGFR (0.50) ALDH1A1KDM4EGAACA1CA2
SCHEMBL14533804 0.82 ALDH1A1 (0.47) ALDH1A1MAPTKDM4EHPGDALOX15
SCHEMBL5392742 0.81 ALDH1A1 (0.51) ALDH1A1MAPTKDM4EHPGDALOX15
SCHEMBL5392736 0.81 ALDH1A1 (0.51) ALDH1A1MAPTKDM4EHPGDALOX15
SCHEMBL6169905 0.80 ALDH1A1 (0.50) ALDH1A1MAPTKDM4EHPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 — — EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 — — US disclosed
Send feedback